Conrad Bleul

Title: Conrad Bleul: Innovator in Human Papillomavirus Research

Introduction

Conrad Bleul is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of medical research, particularly in the study of human papillomavirus (HPV). With a total of two patents to his name, Bleul's work has implications for vaccine development and disease prevention.

Latest Patents

Bleul's latest patents focus on seroreactive epitopes on proteins of human papillomavirus HPV18. These inventions relate to the identification of specific epitopes that can be targeted for vaccine development. The patents also include peptides with amino-acid sequences that correspond to these seroreactive epitopes, which can be utilized in creating effective vaccines against HPV.

Career Highlights

Throughout his career, Conrad Bleul has worked with prominent companies in the diagnostics and biotechnology sectors. Notably, he has been associated with Behring Diagnostics GmbH and Dade Behring Marburg GmbH. His work in these organizations has allowed him to contribute to advancements in medical diagnostics and therapeutic solutions.

Collaborations

Bleul has collaborated with esteemed colleagues in his field, including Lutz Gissmann and Martin Muller. These partnerships have fostered innovation and have been instrumental in the development of his research.

Conclusion

Conrad Bleul's contributions to HPV research and vaccine development highlight his role as an influential inventor in the medical field. His patents and collaborations reflect a commitment to advancing healthcare solutions.